Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2016-06-23 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MOLLEGES (13940), Bouches-du-Rhone
PHARMACIE JEAN-CHARBONNIERE C. : revenue, balance sheet and financial ratios
PHARMACIE JEAN-CHARBONNIERE C. is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MOLLEGES (13940),
this company of category PME
shows in 2023 a revenue of 1.8 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE JEAN-CHARBONNIERE C. (SIREN 821149614)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
1 789 519 €
1 576 133 €
N/C
N/C
N/C
N/C
945 204 €
Net income
71 692 €
106 114 €
104 690 €
155 918 €
127 816 €
89 587 €
110 502 €
103 168 €
43 420 €
EBITDA
N/C
N/C
141 641 €
190 650 €
N/C
N/C
N/C
N/C
55 295 €
Net margin
N/C
N/C
5.9%
9.9%
N/C
N/C
N/C
N/C
4.6%
Revenue and income statement
In 2025, PHARMACIE JEAN-CHARBONNIERE C. generates positive net income of 72 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 43 k€ -> 72 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
71 692 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 43%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
42.806%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
61.258%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE JEAN-CHARBONNIERE C.
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
331.385
221.119
157.104
124.635
92.164
70.358
50.606
43.727
42.806
Financial autonomy
20.242
26.414
33.909
39.146
45.643
52.135
57.326
59.032
61.258
Repayment capacity
19.158
None
None
None
None
4.012
4.455
None
None
Cash flow / Revenue
4.912%
None%
None%
None%
None%
9.462%
5.936%
None%
None%
Sector positioning
Debt ratio
42.812025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Good
In 2025, the debt ratio of PHARMACIE JEAN-CHARBONNIE... (42.81) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
61.26%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Good
In 2025, the financial autonomy of PHARMACIE JEAN-CHARBONNIE... (61.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.46 years2023
2023
Q1: 0.95 years
Med: 3.59 years
Q3: 7.48 years
Average
In 2023, the repayment capacity of PHARMACIE JEAN-CHARBONNIE... (4.46) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 271.55. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
271.55
Liquidity indicators evolution PHARMACIE JEAN-CHARBONNIERE C.
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
177.302
172.796
213.204
238.572
264.057
321.442
253.365
244.649
271.55
Interest coverage
11.71
None
None
None
None
4.362
3.767
None
None
Sector positioning
Liquidity ratio
271.552025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Excellent+5 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE JEAN-CHARBONNIE... (271.55) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Interest coverage
3.77x2023
2023
Q1: 0.38x
Med: 2.71x
Q3: 6.47x
Good
In 2023, the interest coverage of PHARMACIE JEAN-CHARBONNIE... (3.8x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE JEAN-CHARBONNIERE C.
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
73 518 €
0 €
0 €
0 €
0 €
77 688 €
122 528 €
0 €
0 €
Inventory turnover (days)
33
0
0
0
0
20
23
0
0
Customer payment term (days)
7
0
0
0
0
9
4
0
0
Supplier payment term (days)
47
0
0
0
0
39
43
0
0
Positioning of PHARMACIE JEAN-CHARBONNIERE C. in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE JEAN-CHARBONNIERE C. is estimated at
1 138 835 €
(range 772 819€ - 1 786 990€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
772k€1138k€1786k€
1 138 835 €Range: 772 819€ - 1 786 990€
NAF 5 année 2025
Valuation method used
Net Income Multiple
71 692 €
×
15.9x
=1 138 836 €
Range: 772 819€ - 1 786 990€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE JEAN-CHARBONNIERE C. with other companies in the same sector:
Frequently asked questions about PHARMACIE JEAN-CHARBONNIERE C.
What is the revenue of PHARMACIE JEAN-CHARBONNIERE C. ?
The revenue of PHARMACIE JEAN-CHARBONNIERE C. in 2023 is 1.8 M€.
Is PHARMACIE JEAN-CHARBONNIERE C. profitable?
Yes, PHARMACIE JEAN-CHARBONNIERE C. generated a net profit of 72 k€ in 2025.
Where is the headquarters of PHARMACIE JEAN-CHARBONNIERE C. ?
The headquarters of PHARMACIE JEAN-CHARBONNIERE C. is located in MOLLEGES (13940), in the department Bouches-du-Rhone.
Where to find the tax return of PHARMACIE JEAN-CHARBONNIERE C. ?
The tax return of PHARMACIE JEAN-CHARBONNIERE C. is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE JEAN-CHARBONNIERE C. operate?
PHARMACIE JEAN-CHARBONNIERE C. operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart